QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)

Vera Therapeutics (VERA) Insider Trading & Ownership

$37.97
-1.51 (-3.82%)
(As of 01:27 PM ET)

Vera Therapeutics (NASDAQ:VERA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$11.88 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$40.54 M
Get VERA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VERA Insider Buying and Selling by Quarter

Vera Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/10/2024Joseph R YoungSVPSell5,714$40.00$228,560.00  
4/3/2024Sean GrantCFOSell99,828$39.61$3,954,187.08  
3/25/2024Maha KatabiDirectorSell340,000$40.50$13,770,000.00  
3/21/2024Maha KatabiDirectorSell81,009$44.20$3,580,597.80  
1/30/2024Maha KatabiDirectorBuy161,290$31.00$4,999,990.00  
1/10/2024Commodore Capital LpMajor ShareholderSell1,050,000$18.00$18,900,000.00  
8/21/2023Celia LinInsiderSell1,490$16.65$24,808.50  
8/21/2023Marshall FordyceCEOSell5,210$16.66$86,798.60  
6/23/2023Sean GrantCFOBuy5,000$16.60$83,000.00  
6/20/2023Commodore Capital LpMajor ShareholderBuy448,217$15.17$6,799,451.89  
(Data available from 1/1/2013 forward)

VERA Insider Trading Activity - Frequently Asked Questions

Who is on Vera Therapeutics's Insider Roster?

The list of insiders at Vera Therapeutics includes Beth C Seidenberg, Carlyle Group Inc., Celia Lin, Commodore Capital Lp, Joanne Curley, Joseph R Young, Llp Abingworth, Maha Katabi, Marshall Fordyce, Patrick G Enright, Sean Grant, and Sofinnova Venture Partners X,. Learn more on insiders at VERA.

What percentage of Vera Therapeutics stock is owned by insiders?

21.70% of Vera Therapeutics stock is owned by insiders. Learn more on VERA's insider holdings.

Which Vera Therapeutics insiders have been buying company stock?

The following insiders have purchased VERA shares in the last 24 months: Beth C Seidenberg ($2,000,102.98), Commodore Capital Lp ($6,799,451.89), Maha Katabi ($4,999,990.00), Patrick G Enright ($11,999,995.00), Sean Grant ($151,000.00), and Sofinnova Venture Partners X, ($1,999,998.00).

How much insider buying is happening at Vera Therapeutics?

Insiders have purchased a total of 2,898,308 VERA shares in the last 24 months for a total of $27,950,537.87 bought.

Which Vera Therapeutics insiders have been selling company stock?

The following insiders have sold VERA shares in the last 24 months: Carlyle Group Inc. ($200,981.25), Celia Lin ($24,808.50), Commodore Capital Lp ($18,900,000.00), Joanne Curley ($1,365,447.38), Joseph R Young ($228,560.00), Maha Katabi ($17,350,597.80), Marshall Fordyce ($1,529,810.61), and Sean Grant ($3,954,187.08).

How much insider selling is happening at Vera Therapeutics?

Insiders have sold a total of 1,741,087 Vera Therapeutics shares in the last 24 months for a total of $43,554,392.62 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:VERA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners